A federal judge in Connecticut has denied most of Cigna Health and Life Insurance’s claims in its request to dismiss a lawsuit which alleges it artificially inflated prescription drug costs in violation of the health insurance policies of its clients.

The Monday ruling by U.S. District Judge Warren Eginton means the class-action lawsuit against both Cigna and OptumRx Inc. will move forward. The insurance giant hired OptumRx as its pharmacy benefits manager to negotiate drug prices on behalf of Cigna and the Cigna network.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]